Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 3, 1997, Pages 297-310

  Zhuo, Jialong ^a   Casley, David ^a   Murone, Carmel ^a   Mendelsohn, Frederick A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE; Blood vessels; In vitro autoradiography; Perindopril; Rabbit

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; N (1 CARBOXY 3 PHENYLPROPYL)LYSYLPROLINE 4 HYDROXYBENZAMIDINE; PERINDOPRIL; PERINDOPRILAT; RENIN;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY ENDOTHELIUM; ARTICLE; AUTORADIOGRAPHY; BLOOD PRESSURE; BLOOD VESSEL WALL; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMORAL ARTERY; HEART; KIDNEY; LONG TERM CARE; LUNG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RABBIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030940173     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199703000-00001     Document Type: Article

References (40)

1. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
2. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system. Circ Res 1991;68:905-21.
3. Johnston CI. The renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens 1992; 10(suppl 7):S13-26.
4. Mendelsohn FAO. Angiotensin II: evidence for its role as an intrarenal hormone. Kidney Int 1982;22:78-81.
5. Dzau VJ, Re RN. Evidence for the existence of renin in the heart. Circulation 1987;73:I-134-6.
6. Unger T, Badoer E, Ganten D, Lang RE, Rettig R. Brain angiotensin: pathways and pharmacology. Circulation 1988;77:140-54.
7. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992;54:227-41.
8. Navar LG, Rosivall L. Contribution of the renin-angiotensin system to the control of intrarenal haemodynamics. Kidney Int 1984;25:857-68.
9. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69:475-82.
10. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991;9:3-15.
11. Cambien F, Poirier O, Lecerf L, Evans A, Cambou. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
12. Unger T, Gohlke P, Ganten D, Lang RE. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall. J Cardiovasc Pharmacol 1989;13:58-16.
13. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 1987;316:1429-35.
14. Veltmar A, Gohlke P, Unger T. From tissue angiotensin converting enzyme inhibition to antihypertensive effect. Am J Hypertens 1991;4:263S-9S.
15. Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. J Cardiovasc Pharmacol 1994;24:56-13.
16. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FAO. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992;10:615-20.
17. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991;68:141-9.
18. Zhuo J, Allen AM, Yamada H, Sun Y, Mendelsohn FAO. Localization and properties of the angiotensin converting enzyme and angiotensin receptors in the heart. In: Lindpaintner K, Ganten D, eds. The cardiac renin-angiotensin system. New York: Futura, 1994:63-88.
19. 125I-labeled MK351A. J Hypertens 1984;2:41-4.
20. Mendelsohn FAO, Pubic V, Jackson B, Cubela R, Johnston CI. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity. Am J Hypertens 1991;4:220-5S.
21. Kohzuki M, Johnston CI, Chai SY, et al. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography. J Hypertens 1991;9:579-87.
22. Friedland J, Silverstein E. A sensitive fluorimetric assay for serum angiotensin converting enzyme. Am J Clin Pathol 1976;66:416-24.
23. Johnston CI, Millar JA, Casley DJ, McGrath BP, Matthews PG. Hormonal response to angiotensin blockade: comparison between receptor angiotensin and converting enzyme inhibition. Circ Res 1980;46:128-34.
24. Fyhrquist F, Forslund T, Tikkanen I, GronHagen-Riska C. Induction of angiotensin converting enzyme in rat lung with captopril (SQ14225). Eur J Pharmacol 1980;67:473-5.
25. Jackson B, Johnston CI. Angiotensin converting enzyme during acute and chronic enalapril therapy in essential hypertension. Clin Exp Pharmacol Physiol 1984;11:335-60.
26. Caldwell RPB, Seegal BC, Hsu KC, Das M, Softer RL. Angiotensin I converting enzyme: vascular endothelial localization. Science 1976;191:1050-1.
27. Vanhoutte PM, Boulanger CM, Illiano SC, Nagao T, Vidal M, Mombouli JV. Endothelium-dependent effects of converting-enzyme inhibitors. J Cardiovasc Pharmacol 1993;22:510-6.
28. Moroi M, Akatsuka N, Fukazawa M, et al. Endothelium-dependent relaxation by angiotensin converting enzyme inhibitors in canine femoral arteries. Am J Physiol 1994;266:H583-9.
29. Pipili-Synetos E, Manololoulos G, Catravas JD, Maragoudakis ME. Angiotensin converting enzyme activity is present in the endothelium-denuded aorta. Br J Pharmacol 1989;98:333-5.
30. Pipili-Synetos E, Sideri E, Catravas JD, Maragoudakis ME. Endothelium removal does not abolish angiotensin converting enzyme activity from the mesenteric arterial bed of the rat. Biochem Pharmacol 1990;40:1149-51.
31. Saye JA, Singer HA, Peach MJ. Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension 1984;6:216-21.
32. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
33. Unger T, Moursi M, Ganten D, Hermann K, Lang RE. Antihypertensive action of converting enzyme inhibitor perindopril in spontaneously hypertensive rats: comparison with enalapril and ramipril. J Cardiovasc Pharmacol 1986;8:276-85.
34. Cohen ML, Kurz KD. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 1982;220:63-9.
35. Jackson B, Cubela R, Johnston CI. Effect of perindopril on angiotensin converting enzyme in tissues of the rat. J Hypertens 1988;6(suppl 3):S51-4.
36. Sun Y, Mendelsohn FAO. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 1991;18:478-86.
37. Chen BZ, Mendelsohn FAO. Effect of acute and chronic administration of ceronapril on angiotensin converting enzyme in plasma, kidney, lung, brain regions and cerebrospinal fluid of rats. Neuropharmacology 1992;9:929-35.
38. Brunner HR, Nussberger J, Waeber B. Effects of angiotensin converting enzyme inhibition: a clinical point of view. J Cardiovasc Pharmacol 1985;7(suppl):S73-81.
39. Motion JJ, Tree M, Casala-Stenzel J. The effect of captopril on blood pressure and angiotensin I, II, and III in sodium depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme. Clin Sci 1980;58: 445-50.
40. Van Den Berg H, Resplandy G, de Bie AT, Floor W, Bertrand M, Arts CJ. A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of lysine derivative as immunogen to improve the assay specificity. J Pharmaceut Biomed Anal 1991;9:517-24.